Xspray Pharma AB (publ)
SSE:XSPRAY.ST
44 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.93 | 0.134 | 0 | 29.203 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.206 | 0.071 | 7.99 | 6.317 | 0.021 | 0.1 | 0.143 | 0.069 | 0.101 | 0 | 0.346 | 0.346 |
| Cost of Revenue
| 2.349 | 2.701 | 2.449 | 2.23 | 0 | 0 | 2.426 | 2.399 | 2.387 | 2.321 | 2.296 | 2.307 | 2.312 | 1.955 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.049 | -1.896 | -1.578 | -2.919 | -1.055 | -1.181 | -5.03 | 3.132 | -13.008 | 3.781 | 1.517 | 1.517 |
| Gross Profit
| -1.419 | -2.567 | -2.449 | 26.973 | 0 | 0 | -2.426 | -2.399 | -2.387 | -2.321 | -2.296 | -2.307 | -2.312 | -1.955 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.843 | 1.967 | 9.568 | 9.236 | 1.075 | 1.281 | 5.173 | -3.063 | 13.109 | -3.781 | -1.172 | -1.172 |
| Gross Profit Ratio
| -1.526 | -19.157 | 0 | 0.924 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -76.908 | 27.704 | 1.197 | 1.462 | 52.334 | 12.81 | 36.175 | -44.391 | 129.792 | 0 | -3.391 | -3.391 |
| Reseach & Development Expenses
| 15.373 | 18.651 | 12.488 | 5.647 | 9.118 | 13.006 | 17.099 | 1.704 | 1.722 | 1.694 | 33.008 | 1.955 | 1.978 | 1.626 | 1.642 | 1.651 | 1.634 | 1.621 | -1.777 | 1.952 | 1.961 | 1.293 | 5.536 | 0 | 0 | 0 | 4.132 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 38.436 | 48.687 | 34.607 | 52.529 | 41.489 | 22.853 | 38.824 | 26.328 | 27.429 | 17.021 | 19.257 | 11.878 | 15.067 | 12.182 | 13.97 | 10.26 | 14.319 | 8.552 | 17.725 | 8.472 | 0 | 0 | 0 | 1.847 | 3.268 | 1.811 | 2.594 | 2.163 | 2.454 | 1.398 | 1.382 | 0.978 | 0 | 0 |
| Selling & Marketing Expenses
| -2.349 | -2.701 | 6.932 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.257 | 6.873 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 36.087 | 45.986 | 41.539 | 52.529 | 41.489 | 22.853 | 38.824 | 26.328 | 27.429 | 17.021 | 19.257 | 11.878 | 15.067 | 12.182 | 13.97 | 10.26 | 14.319 | 8.552 | 17.725 | 8.472 | 9.257 | 6.873 | 10.041 | 1.847 | 3.268 | 1.811 | 2.594 | 2.163 | 2.454 | 1.398 | 1.382 | 0.978 | 2.241 | 2.241 |
| Other Expenses
| 0.265 | 0 | 0 | 0 | 0 | -0.47 | -2.026 | 0.962 | 0.058 | 0.567 | -0.989 | 0.375 | 0.244 | 0.37 | -0.13 | -0.1 | -0.315 | 0.54 | -0.892 | 0.28 | 0.163 | 0.449 | -6.307 | 4.475 | 5.076 | 2.704 | 3.292 | 1.954 | 2.037 | 1.871 | 1.914 | 1.964 | 0 | 0 |
| Operating Expenses
| 51.46 | 64.637 | 54.027 | 39.235 | 51.262 | 35.389 | 53.897 | 28.994 | 29.209 | 19.282 | 51.276 | 14.208 | 17.289 | 14.178 | 15.482 | 11.811 | 15.638 | 10.713 | 15.056 | 10.704 | 11.381 | 8.615 | 3.734 | 6.322 | 8.344 | 4.515 | 5.885 | 4.117 | 4.491 | 3.269 | 3.296 | 2.942 | 2.403 | 2.403 |
| Operating Income
| -53.809 | -67.338 | -56.476 | -39.236 | -51.261 | -35.389 | -55.587 | -28.994 | -29.21 | -19.282 | -52.277 | -14.209 | -17.289 | -14.177 | -15.294 | -11.811 | -15.639 | -10.714 | -15.056 | -10.704 | -11.381 | -8.615 | -10.5 | -4.355 | -6.766 | -1.596 | -4.792 | -2.836 | 0.682 | -6.332 | 9.814 | -6.723 | -3.575 | -3.575 |
| Operating Income Ratio
| -57.859 | -502.522 | 0 | -1.344 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.971 | -61.338 | -0.847 | -0.253 | -233.222 | -28.36 | 4.769 | -91.768 | 97.168 | 0 | -10.346 | -10.346 |
| Total Other Income Expenses Net
| 0.189 | -0.443 | 1.963 | 0.294 | -0.141 | 0.562 | 0.367 | 0.343 | 0.345 | 0.348 | -0.334 | 0.318 | 0.337 | 0.266 | 0.51 | 0.251 | 0.292 | 0.181 | -0.577 | 0.121 | 0.329 | 0.112 | -0.674 | 0.239 | -0.023 | 0.024 | 0.099 | 0.014 | -0.001 | 0.002 | -0.037 | -0.001 | 0 | 0 |
| Income Before Tax
| -53.62 | -67.781 | -54.513 | -38.942 | -51.402 | -34.827 | -55.22 | -28.651 | -28.865 | -18.934 | -51.944 | -13.89 | -16.952 | -13.912 | -14.972 | -11.56 | -15.346 | -10.532 | -15.633 | -10.583 | -11.052 | -8.503 | -10.597 | -4.116 | -6.789 | -1.596 | -4.711 | -2.836 | 0.681 | -6.332 | 9.776 | -6.724 | -3.575 | -3.575 |
| Income Before Tax Ratio
| -57.656 | -505.828 | 0 | -1.333 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -51.442 | -57.972 | -0.85 | -0.253 | -229.309 | -28.36 | 4.762 | -91.768 | 96.792 | 0 | -10.346 | -10.346 |
| Income Tax Expense
| 0.04 | 0.04 | -0.017 | 0.412 | 0.294 | -0.562 | -0.367 | -0.343 | -0.345 | -0.348 | 0.334 | 0.319 | 0.34 | 0.266 | 0.511 | 0.251 | 0.292 | 0.185 | 0.944 | 0.121 | 0 | 0.222 | -0.666 | 0.239 | 0 | 0.024 | 0.098 | 0.014 | 0 | 0.002 | 0.022 | 0 | 0 | 0 |
| Net Income
| -53.58 | -67.741 | -54.496 | -38.942 | -51.402 | -34.265 | -54.853 | -28.308 | -28.52 | -18.586 | -51.944 | -13.89 | -16.952 | -13.912 | -14.972 | -11.56 | -15.346 | -10.532 | -15.633 | -10.583 | -11.052 | -8.503 | -10.597 | -4.116 | -6.789 | -1.596 | -4.711 | -2.836 | 0.681 | -6.332 | 9.776 | -6.724 | -3.575 | -3.575 |
| Net Income Ratio
| -57.613 | -505.53 | 0 | -1.333 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -51.442 | -57.972 | -0.85 | -0.253 | -229.309 | -28.36 | 4.762 | -91.768 | 96.792 | 0 | -10.346 | -10.346 |
| EPS
| -1.64 | -2.17 | -1.85 | -1.59 | -2.27 | -1.5 | -2.45 | -1.37 | -1.38 | -0.9 | -2.7 | -0.72 | -0.88 | -0.73 | -0.89 | -0.68 | -0.91 | -0.62 | -1.04 | -0.7 | -0.73 | -0.56 | -0.77 | -0.3 | -0.5 | -0.12 | -0.38 | -0.23 | 0.11 | -1 | 2.46 | -1.05 | -1.08 | -1.08 |
| EPS Diluted
| -1.64 | -2.17 | -1.85 | -1.59 | -2.27 | -1.5 | -2.45 | -1.37 | -1.38 | -0.9 | -2.7 | -0.71 | -0.88 | -0.72 | -0.89 | -0.66 | -0.88 | -0.61 | -1.04 | -0.68 | -0.71 | -0.54 | -0.77 | -0.3 | -0.5 | -0.12 | -0.38 | -0.23 | 0.11 | -0.99 | 2.46 | -0.54 | -1.08 | -1.08 |
| EBITDA
| -51.46 | -64.637 | -54.027 | -36.594 | -50.845 | -34.827 | -52.794 | -26.243 | -26.475 | -16.613 | -49.648 | -11.582 | -14.637 | -11.957 | -13.044 | -9.63 | -13.421 | -8.621 | -15.609 | -8.441 | -8.876 | -6.74 | -8.145 | -3.413 | -6.079 | -1.329 | -3.912 | -2.306 | 0.894 | -6.166 | 10.012 | -6.56 | -3.412 | -3.412 |
| EBITDA Ratio
| -55.333 | -482.366 | 0 | -1.253 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -39.539 | -48.07 | -0.761 | -0.21 | -190.393 | -23.06 | 6.252 | -89.362 | 99.129 | 0 | -9.876 | -9.876 |